JPMORGAN CHASE & CO - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 60 filers reported holding IMMUNE DESIGN CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$1,675,000
+143.8%
286,375
-45.9%
0.00%
Q4 2018$687,000
-50.6%
528,964
+31.3%
0.00%
Q3 2018$1,390,000
-25.1%
402,906
-1.2%
0.00%
Q2 2018$1,856,000
-33.3%
407,844
-51.6%
0.00%
-100.0%
Q1 2018$2,782,000
-22.2%
842,927
-8.0%
0.00%0.0%
Q4 2017$3,575,000
-34.1%
916,589
+81.6%
0.00%0.0%
Q3 2017$5,425,000
+4.8%
504,675
-4.9%
0.00%0.0%
Q2 2017$5,175,000
+213.8%
530,702
+118.7%
0.00%
Q1 2017$1,649,000
+10.3%
242,693
-10.7%
0.00%
Q4 2016$1,495,000
-27.4%
271,744
-0.0%
0.00%
-100.0%
Q3 2016$2,060,000
+2.3%
271,802
+10.2%
0.00%0.0%
Q2 2016$2,014,000
+8.4%
246,675
+72.6%
0.00%
Q1 2016$1,858,000
-34.2%
142,925
+1.7%
0.00%
-100.0%
Q4 2015$2,824,000
+51.8%
140,600
-7.8%
0.00%
Q3 2015$1,860,000
-45.5%
152,425
-7.7%
0.00%
-100.0%
Q2 2015$3,410,000
-20.6%
165,084
-18.9%
0.00%0.0%
Q1 2015$4,297,000
-39.2%
203,550
-11.3%
0.00%
-50.0%
Q4 2014$7,063,000
+47.1%
229,450
-15.6%
0.00%
+100.0%
Q3 2014$4,801,000271,8180.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q3 2015
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders